GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » PEG Ratio

RDTCF (Rapid Dose Therapeutics) PEG Ratio : 0.00 (As of Mar. 31, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Rapid Dose Therapeutics's PE Ratio without NRI is 0.00. Rapid Dose Therapeutics's 5-Year EBITDA growth rate is 27.10%. Therefore, Rapid Dose Therapeutics's PEG Ratio for today is 0.00.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Rapid Dose Therapeutics's PEG Ratio or its related term are showing as below:



RDTCF's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.36
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Rapid Dose Therapeutics PEG Ratio Historical Data

The historical data trend for Rapid Dose Therapeutics's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics PEG Ratio Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Rapid Dose Therapeutics Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Rapid Dose Therapeutics's PEG Ratio

For the Biotechnology subindustry, Rapid Dose Therapeutics's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Dose Therapeutics's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's PEG Ratio falls into.


;
;

Rapid Dose Therapeutics PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Rapid Dose Therapeutics's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/27.10
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Rapid Dose Therapeutics  (OTCPK:RDTCF) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Rapid Dose Therapeutics PEG Ratio Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Dose Therapeutics Business Description

Traded in Other Exchanges
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Rapid Dose Therapeutics Headlines

From GuruFocus

Rapid Dose Therapeutics Corp Announces Proposed Private Placement

By Business Wire Business Wire 05-26-2022

Rapid Dose Announces Change of Auditor

By Business Wire Business Wire 05-17-2023

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

By Business Wire Business Wire 07-28-2022

Rapid Dose Announces Proposed Private Placement Financing

By Business Wire Business Wire 06-03-2023

Rapid Dose Announces Revocation of Cease Trade Order

By Business Wire Business Wire 05-02-2023

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

By Business Wire Business Wire 08-25-2022

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

By Business Wire Business Wire 08-11-2022